RankingsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Income before tax

Fuji Pharma Co.,Ltd.【JP:4554】

Market cap
¥47.6B
P/E ratio
12.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Sep 30, 20254,459+0.31%
Sep 30, 20244,445-1.64%
Sep 30, 20234,519+21.32%
Sep 30, 20223,725+14.62%
Sep 30, 20213,250+8.95%
Sep 30, 20202,983-28.45%
Sep 30, 20194,169-6.78%
Sep 30, 20184,472-3.37%
Sep 30, 20174,628+42.36%
Sep 30, 20163,251+4.90%
Sep 30, 20153,099-3.10%
Sep 30, 20143,198-5.27%
Sep 30, 20133,376+25.13%
Sep 30, 20122,698-23.89%
Sep 30, 20113,545

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)